Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esophageal Infections.

Nassar1, Gregg

  • 1Infectious Diseases Section, Medicine Service, Dallas Veterans Affairs Medical Center, 4500 S. Lancaster Road, Dallas, TX 75216.

Current Treatment Options in Gastroenterology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infectious Enteritis.

Current treatment options in gastroenterology·2000
Same author

Examination of the Hydrotropic Effect of Sodium p-Toluenesulfonate on a Nonionic Surfactant (C(12)E(6)) Solution.

Journal of colloid and interface science·2000
Same author

Optimizaition of a low-frequency ultrasonic technique to monitor the change in physical states in viscoelastic media: gelation process

The Journal of the Acoustical Society of America·2000
Same author

The Radial Artery: An Applicable Approach to Complex Coronary Angioplasty.

The Journal of invasive cardiology·2000
Same author

Fermentability of the hemicellulose-derived sugars from steam-exploded softwood (douglas fir)

Biotechnology and bioengineering·1999
Same author

Counterion Exchange Selectivity in Detergent-Polymer Aggregates

Journal of colloid and interface science·1997
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Infectious esophagitis in immunocompromised patients often requires endoscopy for diagnosis and treatment guidance. Early diagnosis and appropriate therapies like fluconazole or valacyclovir improve patient outcomes and reduce malnutrition risks.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Immunology

Background:

  • Infectious esophagitis is a significant complication in immunocompromised individuals, leading to discomfort and malnutrition.
  • Diagnosis often necessitates laboratory tests and esophagoscopy for mucosal visualization and biopsies.
  • Empiric antifungal or antiherpetic treatments are common but may require endoscopic guidance.

Purpose of the Study:

  • To review the diagnostic and therapeutic strategies for infectious esophagitis in immunocompromised patients.
  • To highlight the role of esophagoscopy in guiding treatment decisions.
  • To discuss preferred pharmacologic agents for common infectious etiologies.

Main Methods:

  • Literature review of infectious esophagitis in immunocompromised populations.

Related Experiment Videos

  • Analysis of diagnostic modalities including laboratory testing and esophagoscopy.
  • Evaluation of treatment guidelines for Candida and herpetic esophagitis.
  • Consideration of specific agents like fluconazole, valacyclovir, famciclovir, and thalidomide.

    • Main Results:

    • Esophagoscopy is crucial for definitive diagnosis and guiding therapy when empiric treatment fails or is uncertain.
    • Systemic fluconazole is the preferred treatment for Candida esophagitis.
    • Valacyclovir or famciclovir are recommended for herpetic esophagitis due to efficacy and dosing.
    • Thalidomide may benefit HIV patients with oral and esophageal aphthous ulcerations.

    Conclusions:

    • Effective management of infectious esophagitis relies on accurate diagnosis, often aided by endoscopy.
    • Tailored pharmacologic therapy, guided by etiology, is essential for optimal patient outcomes.
    • Prompt treatment can mitigate complications such as prolonged discomfort and malnutrition.